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Abstract
BACKGROUND: Measles is a highly contagious infectious disease caused by morbillivirus which usually affects 
young children. Once thought to have been eradicated, measles continues to be the leading cause of morbidity and 
mortality in the world. 
AIM: The purpose of this research is to analyze the risk factors and clinical characteristics of children hospitalized at 
the Pediatric Clinic under the diagnosis of measles during the epidemic in Sarajevo Canton 2019.
METHOD: We applied a retrospective analysis of medical histories of 23 patients who were hospitalized under the 
diagnosis of measles at the Pediatric Clinic of the Clinical Center in Sarajevo from January to June 2019. We divided 
patients into two groups: Infants and children over one year of age. We diagnosed measles clinically, or through the 
serum IgM ELISA test for measles virus.
RESULTS: A total of 23 patients, aged 1 month to 14 years, were hospitalized at the Pediatric Clinic, accounting for 
3.5% of the total number of the diseased children. The largest numbers of hospitalized patients were infants 9 (39.1%). 
Comorbidities were present in 9 (39.1%) subjects, and the most common complication was bronchopneumonia, 
present in as many as half of the infants. There were four patients who needed mechanical ventilation (17.39%); 
three of whom were infants; and two lethal outcomes (8.69%), both in infancy.
CONCLUSION: Responsible behavior of parents, health professionals, and society as a whole can prevent the 
far-reaching consequences of non-vaccination. Infants are critically endangered, as the most sensitive part of 
population, especially if the collective immunity is impaired.
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Introduction
Measles is a highly contagious infectious 
disease caused by morbillivirus from the 
Paramyxoviridae family. The disease is met in 
endemoepidemic form most commonly in children of 
preschool and early school age. In our region, it shows 
the seasonal pattern of occurrence, with the peak 
incidence in autumn, winter, and spring. The virus is 
transmitted by a drop path from the nose, mouth, or 
throat of an infected person and can remain infectious 
in the air for up to 2 h [1]. There is an estimation of 
1,00,000 deaths worldwide annually, mainly among 
children under 5 years of age [2].
Measles is not a harmless disease. Before 
global vaccination, measles resulted in the death of 2 
to 3 million people worldwide [3]. Once thought to have 
been eradicated, measles continues to be the leading 
cause of morbidity and mortality in the world, although 
the consequences of the disease can be prevented by 
vaccination [4].
Measles is a vaccine preventable disease 
that, according to the World Health Organization 
(WHO), contributed to over 41,000 cases between 
January 2018 and June 2018. Of these 41,000 cases, 
37 have resulted in death. The greatest factor that 
has contributed to this increase is a low vaccination 
rate compared to the previous years [5]. Some highly 
developed countries have been able to eradicate 
measles as a result of comprehensive vaccination and 
surveillance programs. In particular, certain parts of 
Europe, Central and South America, Asia, the Pacific, 
and Africa have been the most affected by measles. 
In these regions, a lack of vaccination is the greatest 
contributor to the development of the disease. In 2014 
and 2015, more than 5000 people became ill in the 
measles epidemic in Bosnia and Herzegovina. In only 
one Canton, Sarajevo Canton, out of the ten existing 
cantons in the Federation of Bosnia and Herzegovina, 
840 patients were registered from the beginning of 
2019 to June 28, 2019. The lack of vaccination is a 
major risk factor for the development of the disease. 
Other factors include immunosuppression, preterm 
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infants, and the absence of maternal vaccination. 
Measles can cause life-threatening complications, and 
around 30% of patients experience multiple system 
and organ complications [6]. Measles infection causes 
immunosuppression and infected individuals are at risk 
of coinfection by respiratory and gastrointestinal viruses 
and secondary bacterial infections, most commonly with 
Staphylococcus aureus, Streptococcus pneumonia, 
and Haemophilus influenzae. Diarrhea is a complication 
that occurs with an incidence of 8%. Otitis media is most 
common in small children. The incidence of encephalitis 
and acute disseminating encephalomyelitis is 1 in 1000 
cases. Subacute sclerotising panencephalitis (SSPE) is 
a late-onset lethal degenerative disease of the CNS, 
occurring usually 7–10 years after the initial measles 
infection [7]. Pneumonia, which is also the most 
common cause of morbidity and mortality, can occur as 
the most common and most serious complication of this 
disease [8].
The aim of this research is to analyze the risk 
factors and clinical characteristics of children hospitalized 
at the Pediatric Clinic under the diagnosis of measles 
during morbilli epidemic in Sarajevo Canton 2019.
Patients and Methods
We retrospectively analyzed medical histories 
of patients hospitalized due to measles at the Pediatric 
Clinic of the Clinical Centre of University in Sarajevo from 
January to June 2019. We divided patients into two groups 
according to age. The first group consisted of infants 
and the second group of children older than one year of 
age. The average length of hospital stay was 12 days. 
We analyzed the socio-demographic characteristics, 
vaccine status, comorbidity, complications, and the 
outcome of the disease. Our patients had the following 
diseases as comorbidities: Steroid-resistant nephrotic 
syndrome, Otahara syndrome (early infantile epileptic 
encephalopathy), epilepsy, complex congenital heart 
defects, renal dysplasia, cerebral palsy, Rett syndrome, 
and surgery for esophageal atresia. Patients were 
diagnosed clinically, based on the specific clinical 
characteristics of the measles or by ELISA test for 
serum IgM for measles virus. The inclusion criteria 
were all hospitalized children aged 0–18 years old, in 
whom we confirmed the diagnosis of measles. The 
exclusion criteria were all hospitalized children aged 
0–18 years, who were suspected of measles, but we 
did not prove the disease. The results of the research 
are shown in the form of numbers and percentages. We 
have obtained permission from the Ethics Committee 
for data analysis.
Results
A total of 23 patients aged from 1 month to 
14 years were hospitalized at the Pediatric Clinic 
which represented 3.58% (23/642) of the total number 
of patients in the Sarajevo Canton, who were under 
pediatric care. Others who required hospitalization, but 
were not complicated cases, were hospitalized at the 
clinic for infectious diseases at the Clinical Center of 
University in Sarajevo, and their data were not available. 
According to the official data from the Institute for Public 
Health of the Sarajevo Canton, between January and 
June 2019, a total of 840 cases of measles were 
recorded in the Sarajevo Canton, of which 642 (76.4%) 
were between the ages of 0–18.
In our sample, there were 10 (43.5%) male and 
13 (56.5%) female patients in total. In terms of age, for 
the descriptive statistics, we divided patients into five 
groups. In the 0–6 month group, there were 4 (17.4%) 
patients; in the 6–12 month group, there were 5 (21.7%) 
patients; in the 1–2 year group, there were 6 (26.1%) 
patients; in the group from 2 to 5 years, there were 5 
(21.7%) patients, while in the age group of 8–14 years, 
there were 3 (13%) patients. In comparison to the official 
data from the Institute for Public Health of Sarajevo 
Canton, 21% (4/19) of patients were hospitalized in the 
1st age group, 7.93% (5/63) in the 2nd age group, 5.3% 
(6/113) in the 3rd age group, 1.83% (5/273) in the 4th age 
group, and 3% (3/100) in the 5
th age group, which are 
presented in Figure 1. Comorbidities were present 
in 9 (39.1%) out of the total number of hospitalized 
patients and one-third of children with comorbidities 
had respiratory failure and required mechanical 
ventilation. The most common complication in patients 
was bronchopneumonia, present in 12 (52.17%) 
patients. Among those hospitalized, 20 (86.95%) 
were unvaccinated, while 3 (13.04%) children were 
incompletely vaccinated, that is, they received only one 
dose of the MMR vaccine.
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Figure 1: A comparison of hospitalized patients at the Pediatric Clinic 
to the official registered number of diseased patients in Sarajevo 
Canton
If we divide patients into two age groups: 
Group up to 1 year of age and group more than 1 year 
of age, we get data that in the first group, there were 
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9 (39.13%), and in the second group, there were 14 
(60.86%) patients. In the first group, comorbidities were 
present in almost half of the patients or 4 (44.44%), of 
whom two children required mechanical ventilation, 
one had myocarditis, and one died. In the first group 
(up to 1 year of age), there were three children with 
mechanical ventilation, two with myocarditis, and one 
with CNS complications. In the second group (1 year+), 
there were 5 (35.71%) patients, in whom comorbidities 
were present, of which one child was on mechanical 
ventilation. In the group of children with no comorbidity 
but older than 1, only one child had CNS complications 
such as febrile convulsions. Both lethal outcomes 
were in the group up to 1 year of age. All the data are 
represented in Tables 1 and 2.
Discussion
Out of the total number of hospitalized patients 
at the Pediatric Clinic, the largest percentage were 
infants, with the largest number of hospitalizations in 
March. This is an expected result, as measles usually 
occurs during spring and early summer, although they 
can be seen at any time of the year [7].
Infant age is also a risk factor for developing 
measles [9]. In general, antibodies obtained from the 
mother and through breastfeeding have a protective 
effect up to about 6 months, and the first dose of the MMR 
vaccine is given at the age of 12 months. In Bosnia and 
Herzegovina, measles vaccination is administered in two 
doses: The first dose after completing the 1st year of life 
and the second dose when enrolling in the first grade of 
primary school, at the age of 6. The first dose of the MMR 
vaccine protects children in about 93–95% from the onset 
of the disease. With the second dose of the vaccine, they 
are protected almost 100% [10], [11]. To maintain collective 
immunity and prevent epidemic outbreaks, vaccination 
coverage needs to be over 93% [12].
Measles can occur at any age, but they most 
commonly occur in children under the age of 5 [1], [13]. 
Boys and girls are equally affected by measles [14].
Comorbidity is also a risk factor for the 
development of a more severe clinical picture in measles 
patients. Of the total nine patients with comorbidities, 
three developed respiratory failure. Most patients with 
respiratory failure and comorbidities were in infant age. 
Furthermore, both deaths were at this age.
Complications of measles occur in 10–40% 
of cases. They are more common and more serious in 
smaller children [15], and bronchopneumonia may be 
the most common complication in patients [16]. Our 
research results are in line with the literature data, citing 
bronchopneumonia as the most common complication, 
present in as many as 52.17% of patients. Both 
patients who died (8.69%) had bronchopneumonia 
and myocarditis as complications. Neurological 
complications include febrile seizures, primary measles 
encephalitis, acute post-infectious encephalomyelitis, 
measles inclusion body encephalitis, and subacute 
sclerosing panencephalitis [17]. In our patients, there 
were no serious acute neurological complications. 
CNS complications in the form of febrile seizures were 
reported by one patient (4.35%) in the group of children 
over one year of age.
Myocarditis can also occur as a complication of 
measles [18]. Both of our patients who died (8.69%) had 
Table 1: Incidence of pneumonia as the most common complication in hospitalized patients, according to the age groups. Incidence 
in children with and without comorbidities
Age 0-1 years
9 (39.13%)
1-14 years
14 (60.87%)
Yes  No Yes No
Pneumonia 6 (66.66%) 3 (33.33%) 6 (42.85%) 8 (57.14%)
Comorbidities 4 (44.44%) 5 (55.55%) 5 (35.71%) 9 (64.29%)
Pneumonia in children with 
comorbidities
Pneumonia in children without 
comorbidities
Pneumonia in children with 
comorbidities
Pneumonia in children without 
comorbidities
Yes
3 (75%)
No
1 (25%)
Yes
3 (20%)
No
2 (80%)
Yes
2 (40%)
No
3 ( 60%)
Yes
4 (44.4%)
No
5 (55.5%)
Table 2: Incidence of severe complications in hospitalized patients according to the age groups. Incidence in children with and 
without comorbidities
Age 0-1 years
9 (39.13%)
1-14 years
14 (60.87%)
Yes No Yes No
Complications 4 (44.44%) 5 (55.55%) 3 (21.42%) 11 (78.57%)
Mechanical ventilation 3 (33.33%) 6 (66.66%) 1 (7.14%) 13 (92.85%)
Myocarditis 2 (22.22%) 7 (77.77%) 0 (0%) 14 (100%)
CNS complications 1 (11.11%) 8 (88.88%) 2 (14.28%) 12 (85.71%)
Exitus lethalis 2 (22.22%) 7 (77.77%) 0 (0%) 14 (100%)
Comorbidities 4 (44.44%) 5 (55.55%) 5 (35.71%) 9 (64.29%)
Complications in children 
with comorbidities
Complications in children 
without comorbidities
Complications in children with 
comorbidities
Complications in children without 
comorbidities
Yes
3 (75%)
No
1 (25%)
Yes 
1 (20%)
No
4 (80%)
Yes
2 (40%)
No
3 ( 60%)
Yes
1 (11.1%)
No
8 (88.8%)
Mechanical ventilation 2 (50%) 1 (25%) 1 (20%)  4 (80%) 1 (20%) 3 ( 60%) 0 (0%) 8 (88.8%)
Myocarditis 1 (25%) 1 (25%) 1 (20%)  4 (80%) 0 (0%) 3 ( 60%) 0 (0%) 8 (88.8%)
CNS complications 1 (25%) 1 (25%) 0 (0%)  4 (80%) 1 (20%) 3 ( 60%) 1 (11.1%) 8 (88.8%)
Exitus lethalis 1 (25%) 1 (25%) 1 (20%)  4 (80%) 0 (0%) 3 ( 60%) 0 (0%) 8 (88.8%)
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bronchopneumonia and myocarditis, and consequently 
respiratory failure, as complications.
Although the measles vaccine has been used 
around the world for over 50 years and has proven to be 
very safe and effective, according to our study results, 
the highest percentage of hospitalized patients had not 
received a single dose of the MMR vaccine. The strong 
anti-vaccine movement as well as the association of 
the MMR vaccine with the development of autism in 
children have also had a strong impact in our area. A 
meta-analysis based on the evidence of five cohort 
studies (n = 12,56,407) and five case–control studies 
(n = 9920) found no evidence of an association between 
MMR vaccination and subsequent development of 
autism or autism spectrum disorders [19]. For now, 
however, there is no clear answer as to when and 
how to respond. The views of the WHO European 
Office (2014) and the United States National Center 
for Immunization on this issue are quite consistent: 
(1) To respect the legitimate concerns of parents; 
(2) always truthfully present the benefits and risks of 
vaccines and involve parents in the decision making; 
(3) complete the facts with examples from life; (4) use 
children to educate parents; (5) adapt messages to the 
needs of the target groups, using different strategies; 
and (6) make journalists aware of the overwhelming 
scientific evidence in support of vaccination. 
Furthermore, numerous studies in the world that has 
addressed this issue have found no correlation between 
the MMR vaccine and the subsequent development of 
autism or the autism spectrum disorder. Consequently, 
the measles epidemic in our country should only be a 
reminder of the failure to vaccinate children. To prevent 
the far-reaching consequences of non-vaccination, it 
is necessary to take certain measures and activities 
in our country. Activities should primarily aim at raising 
public awareness of the importance of vaccination and, 
on the other hand, should encourage pediatricians and 
healthcare professionals, especially at the primary 
care level, to contribute to raising parents’ awareness 
of the importance of vaccination. Only the responsible 
behavior of parents, health professionals, and society 
as a whole can prevent the far-reaching consequences 
of non-vaccination.
Conclusion
Measles can best be prevented by vaccination. 
Continuous education should be conducted in order 
to advance the knowledge of all factors involved in 
the immunization system. Through knowledge on the 
importance of immunization, especially at the level of 
primary health care, public awareness can be raised. 
Infants, as the most vulnerable part of the population, 
are particularly at risk if collective immunity is impaired. 
Even deaths at this age are not uncommon, especially 
when it comes to associated comorbidities, where 
the youngest patients very often have complications 
and develop respiratory failure. Every child’s life is an 
irreparable loss because it is a vaccine-preventable 
disease.
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